Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.
Mol Syst Biol. 2022 Jul;18(7):e11036. doi: 10.15252/msb.202211036.
Signal transduction governs cellular behavior, and its dysregulation often leads to human disease. To understand this process, we can use network models based on prior knowledge, where nodes represent biomolecules, usually proteins, and edges indicate interactions between them. Several computational methods combine untargeted omics data with prior knowledge to estimate the state of signaling networks in specific biological scenarios. Here, we review, compare, and classify recent network approaches according to their characteristics in terms of input omics data, prior knowledge and underlying methodologies. We highlight existing challenges in the field, such as the general lack of ground truth and the limitations of prior knowledge. We also point out new omics developments that may have a profound impact, such as single-cell proteomics or large-scale profiling of protein conformational changes. We provide both an introduction for interested users seeking strategies to study cell signaling on a large scale and an update for seasoned modelers.
信号转导控制着细胞行为,其失调常常导致人类疾病。为了理解这一过程,我们可以使用基于先验知识的网络模型,其中节点代表生物分子,通常是蛋白质,边表示它们之间的相互作用。一些计算方法将非靶向组学数据与先验知识相结合,以估计特定生物学场景中信号网络的状态。在这里,我们根据输入组学数据、先验知识和基础方法学的特点,对最近的网络方法进行了回顾、比较和分类。我们强调了该领域现存的挑战,例如普遍缺乏真实情况和先验知识的局限性。我们还指出了可能产生深远影响的新组学发展,如单细胞蛋白质组学或大规模蛋白质构象变化的分析。我们为有兴趣寻求大规模研究细胞信号的策略的用户提供了一个介绍,也为有经验的建模人员提供了一个更新。